Loading...
Loading...
Application UK00004367167 · Examination
| Application Number | UK00004367167 |
| Status | Examination |
| Owner | ALTX Therapeutics Limited |
| Company Number | 16677457 |
| Filed | 2026-03-31 |
| Type | Individual |
| Feature | Word |
ALTX has a current status of Examination.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations and substances; immunotherapy preparations; pharmaceutical and biological preparations and substances for immunotherapy; therapeutic vaccines; genetic medicines; diagnostic reagents for medical purposes; synthetic peptides, proteins and cells for pharmaceutical purposes; peptides, proteins and cells for medical, diagnostic or therapeutic purposes; in vitro diagnostic reagents, in vivo diagnostic reagents, immunological reagents for medical use; biological reagents for medical/clinical diagnosis; diagnostic kits comprising reagents and medical diagnostic tests; biological reagents for medical research; biological reagents for medical use; biological preparations for medical use; immuno-therapeutic agents; antigen binding molecules, antibodies, antibody fragments; pharmaceutical preparations and substances for the treatment of cancer; biotechnological preparations for the treatment of cancer; immunotherapy preparations for the treatment of cancer; genetic medicines for the treatment of cancer; immunotherapy products in oncology; preparation of therapeutic vaccines in oncology for human use; preparation of immunotherapy products in oncology for human use.
Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; scientific research in the field of chemistry, biochemistry and biology; services of a biological, biochemical or chemical laboratory; performing of biological, biochemical or chemical analysis; cancer diagnostics for scientific purposes; biological and biochemical examination services; tests in laboratories; development of testing methods; research, development, technical design, testing, design and development of software in the field of biology; consultancy and analysis services in the field of immuno-therapeutics and in particular immune-oncology; Pharmaceutical product research and development; Biotechnology research and development; vaccine and immunotherapy research and development; research and development services in relation to pharmaceutical preparations and substances; research and development services in relation to pharmaceutical and biological preparations and substances for immunotherapy; research and development services in relation to gene therapy, cell therapy and genetic medicines; pharmaceutical and biological research and development services in connection with the treatment of cancer; advice, information and consultancy in connection with all of the aforesaid services.
Provision of medical information; Provision of medical information via a website; medical counselling and medical information relating to pharmaceuticals, immunotherapy, immune-therapeutic treatments, therapeutic vaccines and genetic medicines; services of a medical laboratory, providing medical supply for therapy; medical diagnostics; medical monitoring, testing, inspection and analysis services; medical and pharmaceutical consultancy.
'ALTX' is a examination trademark on the UK IPO register, owned by ALTX Therapeutics Limited. The application (UK00004367167) was filed on 31 March 2026.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services).
UK trademark UK00004367167 for the mark 'ALTX' in Class 5, 42, 44 is recorded on the UK IPO register as owned by ALTX Therapeutics Limited. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
No — the UK IPO records the status of UK trademark UK00004367167 for the mark 'ALTX' as examination.
UK trademark UK00004367167 for the mark 'ALTX' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations and substances; immunotherapy preparations; pharmaceutical and biological preparations and substances for immunotherapy; therapeutic vaccines; genetic medicines; diagnostic reagents for medical purposes; synthetic peptides, proteins and cells for pharmaceutical purposes; peptides…
UK trademark UK00004367167 for the mark 'ALTX' was filed at the UK IPO on 31 March 2026.
Trademarks matching "ALTX" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ALTX | 88592741 | 602 | 2019-08-26 |
| ALTX | 86241022 | 601 | 2014-04-03 |
| ALTX TRUST | 86239566 | 601 | 2014-04-02 |
| ALTX | 85822885 | 710 | 2013-01-14 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ALTXATZ | 99638633 | 630 | 2026-02-06 |
| Mark | Ref | Status | Filed |
|---|---|---|---|
| AltX Group | 2389841 | protected | 2023-09-19 |
| AltX Generating Interest | 2223053 | protected | 2021-11-05 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
Australian trademark data is supplied by IP Australia (via IPGOD / IP RAPID) under the Creative Commons Attribution 4.0 International licence.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.